Is this finding relevant? Generalisation and epidemiology

Australian and New Zealand Journal of Public Health

Volumn 20, Issue 1, 1996, Pages 54-56

  Ponsonby, Anne Louise ^a,b   Dwyer, Terence ^a   Couper, David ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

^b The Menzies Foundation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; EPIDEMIOLOGY; HEALTH CARE POLICY; QUALITY CONTROL; STATISTICS;

EID: 0030001006     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1996.tb01336.x     Document Type: Article

References (20)

1. Last JM. A dictionary of epidemiology. 2nd edn. New York: Oxford University Press, 1988.
2. Miettenen O. Design of the study base. In: Theoretical epidemiology. Principles of occurrence research in medicine. New York: Wiley, 1985: 46-68.
3. Pyzdrolwski KL, Kendall DM, Halter JB, Nakhleh RE, et al. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med 1992; 327: 220-6.
4. Rothman KJ. Modern epidemiology. Boston: Little Brown, 1986.
5. Cole P. The evolving case-control study. J Chron Dis 1979; 33: 15-27.
6. Hennekens CH, Buring JE. Epidemiology in medicine. Boston: Little Brown, 1987.
7. Riskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med 1989; 321: 386-8.
8. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 32: 406-12.
9. Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992; 327: 227-33.
10. Bigger JX. The events surrounding the removal of encainide and flecainide from the cardiac arrhythmia suppression trial (CAST) and why CAST is continuing with moricizine. J Am Coll Cardiol 1990; 15: 243-5.
11. Tonkin AM. Treatment of ventricular arrhythmias after CAST. Med J Aust 1992; 156: 488-92.
12. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. BMJ 1976; 2: 1525-36.
13. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 1981; ii: 1129-33.
14. Paffenbarger RS, Hyde RT, Wing AL Chung-chen H. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986; 314: 605-12.
15. Donawho CK, Kripke ML. Lack of correlation between UV-induced enhancement of melanoma development and local suppression of contact hypersensitivity. Exp Dermatol 1992; 1: 20-6.
16. Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow up of Chigaco cohorts. Cardiology 1993; 82: 191-222.
17. Brännström I, Weinhall L, Persson LA, Webster PO, Wall S. Changing social patterns of risk factors for cardiovascular disease in a Swedish community intervention programme. Int J Epidemiol 1993; 22: 1026-37.
18. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the United States. Projections to the year 2000. JAMA 1989; 261: 63-8.
19. Boissel J-P, Collet J-P, Lievre M, Girad P. An effect model for the assessment of drug benefit example of antiarrhythmic drugs in postmyocardial infarction patients. J Cardiovasc Pharmacol 1993; 22: 356-63.
20. Katz D, Foxman B. How well do prediction equations predict? Using receiver operating characteristic curves and accuracy curves to compare validity and generalizability. Epidemiology 1993; 4: 319-26.